H-35 CL TRAUMA Cemented Femoral Stem

NCT05606120 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2026-01-15

No results posted yet for this study

Summary

Study design: monocentric, retrospective, observational and post-market clinical study.

Purpose: To demonstrate the safety and performance of CL TRAUMA femoral stem. The eligible study population is represented by the entire population that underwent a hip replacement with CL TRAUMA femoral stem from 2017 to 2023 at Azienda Ospedaliera di Padova (IT) in accordance with the indication for use of the product.

Conditions

  • Arthroplasty
  • Replacement
  • Hip

Interventions

DEVICE

CL TRAUMA femoral stem

Hip arthroplasty according to the instruction for use.

Sponsors & Collaborators

  • Limacorporate S.p.a

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-01
Primary Completion
2025-01-23
Completion
2025-09-17

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05606120 on ClinicalTrials.gov